Cefotaxime sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cefotaxime sodium and what is the scope of freedom to operate?
Cefotaxime sodium
is the generic ingredient in seven branded drugs marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira, Hospira Inc, Lupin, Sanofi Aventis Us, and Sterimax, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for cefotaxime sodium. One supplier is listed for this compound.
Summary for cefotaxime sodium
| US Patents: | 0 |
| Tradenames: | 7 |
| Applicants: | 12 |
| NDAs: | 17 |
| Drug Master File Entries: | 11 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,803 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | cefotaxime sodium at DailyMed |
Recent Clinical Trials for cefotaxime sodium
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fayoum University Hospital | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for cefotaxime sodium
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for cefotaxime sodium
Anatomical Therapeutic Chemical (ATC) Classes for cefotaxime sodium
US Patents and Regulatory Information for cefotaxime sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050792-001 | Jul 29, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sterimax | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050596-004 | May 20, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wockhardt | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065197-002 | Jun 20, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
